These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16344606)

  • 1. Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease.
    McClain C; Barve S; Joshi-Barve S; Song Z; Deaciuc I; Chen T; Hill D
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):180S-8S. PubMed ID: 16344606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease.
    McClain CJ; Song Z; Barve SS; Hill DB; Deaciuc I
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G497-502. PubMed ID: 15331349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-Adenosylmethionine, cytokines, and alcoholic liver disease.
    McClain CJ; Hill DB; Song Z; Chawla R; Watson WH; Chen T; Barve S
    Alcohol; 2002 Jul; 27(3):185-92. PubMed ID: 12163148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate deficiency, methionine metabolism, and alcoholic liver disease.
    Halsted CH; Villanueva JA; Devlin AM
    Alcohol; 2002 Jul; 27(3):169-72. PubMed ID: 12163145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Vitamin dependent methionine metabolism and alcoholic liver disease.
    Halsted CH
    Clin Chem Lab Med; 2013 Mar; 51(3):457-65. PubMed ID: 23096111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of cytokines, S-Adenosylmethionine, and S-Adenosylhomocysteine in alcohol-induced liver disease and immune suppression.
    Barve S; Joshi-Barve S; Song Z; Hill D; Hote P; Deaciuc I; McClain C
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S38-42. PubMed ID: 16958670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease.
    Song Z; Zhou Z; Uriarte S; Wang L; Kang YJ; Chen T; Barve S; McClain CJ
    Hepatology; 2004 Oct; 40(4):989-97. PubMed ID: 15382170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in alcoholic liver disease.
    An L; Wang X; Cederbaum AI
    Arch Toxicol; 2012 Sep; 86(9):1337-48. PubMed ID: 22367091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease.
    Medici V; Peerson JM; Stabler SP; French SW; Gregory JF; Virata MC; Albanese A; Bowlus CL; Devaraj S; Panacek EA; Rahim N; Richards JR; Rossaro L; Halsted CH
    J Hepatol; 2010 Sep; 53(3):551-7. PubMed ID: 20561703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of ethanol and folate deficiency in development of alcoholic liver disease in the micropig.
    Halsted CH; Villanueva JA; Devlin AM; James SJ
    Trans Am Clin Climatol Assoc; 2002; 113():151-62; discussion 162-3. PubMed ID: 12053707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of abnormal methionine metabolism in alcoholic liver injury.
    Lu SC; Tsukamoto H; Mato JM
    Alcohol; 2002 Jul; 27(3):155-62. PubMed ID: 12163143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of altered methylation in cytokine signaling and proteasome function in alcohol and viral-mediated diseases.
    Kharbanda KK; Bardag-Gorce F; Barve S; Molina PE; Osna NA
    Alcohol Clin Exp Res; 2013 Jan; 37(1):1-7. PubMed ID: 22577887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.
    Purohit V; Abdelmalek MF; Barve S; Benevenga NJ; Halsted CH; Kaplowitz N; Kharbanda KK; Liu QY; Lu SC; McClain CJ; Swanson C; Zakhari S
    Am J Clin Nutr; 2007 Jul; 86(1):14-24. PubMed ID: 17616758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease.
    Song Z; Zhou Z; Deaciuc I; Chen T; McClain CJ
    Hepatology; 2008 Mar; 47(3):867-79. PubMed ID: 18167065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic Liver Disease: Role of Cytokines.
    Neuman MG; Maor Y; Nanau RM; Melzer E; Mell H; Opris M; Cohen L; Malnick S
    Biomolecules; 2015 Aug; 5(3):2023-34. PubMed ID: 26343741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFkappaB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease.
    Stärkel P; De Saeger C; Strain AJ; Leclercq I; Horsmans Y
    Eur J Clin Invest; 2010 Jul; 40(7):575-84. PubMed ID: 20658750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine metabolic pathway in alcoholic liver injury.
    Kharbanda KK
    Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):89-95. PubMed ID: 23232418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes.
    Joshi-Barve S; Barve SS; Butt W; Klein J; McClain CJ
    Hepatology; 2003 Nov; 38(5):1178-87. PubMed ID: 14578856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8 and alcoholic liver disease.
    Huang YS; Wu JC; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):395-401. PubMed ID: 10418175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.